Intraventricular hemorrhage Clinical Trials

1 recruiting

Frequently Asked Questions

Common questions about Intraventricular hemorrhage clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Not Applicable

Intraventricular Catheter System for IVH

Intraventricular Hemorrhage (IVH)
Icahn School of Medicine at Mount Sinai17 enrolled1 locationNCT05970549
Recruiting
Not Applicable

Light Therapy Device for Neonatal Intraventricular Hemorrhage Grade 3 and 4

Intraventricular Hemorrhage of PrematurityHydrocephalus
Rutgers, The State University of New Jersey24 enrolled2 locationsNCT06797219
Recruiting
Phase 1

Safety of Erythropoietin and Melatonin for Very Preterm Infants With Intraventricular Hemorrhage

Intraventricular Hemorrhage of Prematurity
Johns Hopkins University60 enrolled1 locationNCT05617833
Recruiting

Prediction of Intraventricular Hemorrhage Using Echocardiography and Near Infrared Spectroscopy

Intraventricular Hemorrhage of Newborn Grade 2Intraventricular Hemorrhage of Newborn Grade 3Intraventricular Haemorrhage Grade IV
Mount Sinai Hospital, Canada380 enrolled4 locationsNCT05708105
Recruiting
Phase 2

The Safety and Efficacy of Rapamycin on Communicating Hydrocephalus Secondary to Intraventricular Hemorrhage

Communicating HydrocephalusCerebral Intraventricular HemorrhageSecondary Normal Pressure Hydrocephalus+1 more
Beijing Tiantan Hospital53 enrolled1 locationNCT06563817
Recruiting
Not Applicable

Physiologically Based Cord Clamping To Improve Neonatal Outcomes In Moderate And Late Preterm Newborns

SepsisPremature BirthIntraventricular Hemorrhage of Prematurity+3 more
Queen Fabiola Children's University Hospital180 enrolled2 locationsNCT06280872
Recruiting

comparison of umbilical venous catheter versus central lines in incidence of brain hemorrhage in preterm infants

intraventricular hemorrhage in preterm infants
Atef Alshafei200 enrolled1 locationACTRN12617001049369
Recruiting
Phase 3

Zinc supplementation in very low birth weight neonates

Morbidity in very low birth weight neonatesIntraventricular hemorrhage
“V.Betania” Evangelic Hospital of Naples200 enrolled1 locationACTRN12612000823875